Tokyo, Japan

Akio Koda


Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Hoya, JA (1976)
  • Hoya, JP (1982)
  • Tokyo, JP (1986 - 1989)

Company Filing History:


Years Active: 1976-1989

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Akio Koda: Innovator in Antibacterial Agents

Introduction

Akio Koda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 8 patents to his name, Koda's work has been instrumental in advancing medical science.

Latest Patents

Koda's latest patents include innovative compounds such as amino-3-substituted-methyl-3-cephem-4-carboxylic acid and various 7-amino-3-substituted-methyl-3-cephem-4-carboxylic acids. These compounds, along with their lower alkylsily derivatives, serve as valuable intermediates in the preparation of new and novel antibacterial agents. A new process for the preparation of these acids and their derivatives has also been devised, showcasing Koda's commitment to enhancing pharmaceutical development.

Career Highlights

Throughout his career, Koda has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has played a crucial role in research and development. His innovative approaches have led to breakthroughs in the synthesis of antibacterial compounds, contributing to the fight against bacterial infections.

Collaborations

Koda has collaborated with notable colleagues such as Yukiyasu Murakami and Ichiro Isaka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Akio Koda's contributions to the field of antibacterial agents through his patents and collaborations highlight his importance as an inventor. His work continues to influence the pharmaceutical industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…